Cite
HARVARD Citation
Fulcher, G. et al. (2016). Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (1), pp. 82-91. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fulcher, G. et al. (2016). Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (1), pp. 82-91. [Online].